Columbia Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-4,532
Closed -$450K 179
2019
Q3
$450K Hold
4,532
0.12% 125
2019
Q2
$419K Hold
4,532
0.11% 133
2019
Q1
$428K Hold
4,532
0.11% 124
2018
Q4
$290K Hold
4,532
0.09% 132
2018
Q3
$406K Sell
4,532
-900
-17% -$79.5K 0.11% 129
2018
Q2
$431K Sell
5,432
-537
-9% -$44.6K 0.13% 119
2018
Q1
$532K Hold
5,969
0.16% 118
2017
Q4
$623K Hold
5,969
0.18% 111
2017
Q3
$870K Hold
5,969
0.27% 84
2017
Q2
$775K Hold
5,969
0.25% 95
2017
Q1
$742K Hold
5,969
0.25% 90
2016
Q4
$691K Hold
5,969
0.23% 92
2016
Q3
$624K Sell
5,969
-300
-5% -$32.5K 0.22% 100
2016
Q2
$618K Hold
6,269
0.22% 96
2016
Q1
$627K Hold
6,269
0.23% 96
2015
Q4
$750K Sell
6,269
-350
-5% -$40.5K 0.3% 88
2015
Q3
$716K Hold
6,619
0.29% 91
2015
Q2
$766K Hold
6,619
0.29% 93
2015
Q1
$763K Hold
6,619
0.29% 97
2014
Q4
$740K Sell
6,619
-170
-3% -$17.9K 0.28% 94
2014
Q3
$643K Sell
6,789
-1,020
-13% -$92K 0.26% 99
2014
Q2
$671K Sell
7,809
-989
-11% -$75.2K 0.27% 94
2014
Q1
$614K Sell
8,798
-400
-4% -$31.7K 0.27% 90
2013
Q4
$777K Buy
+9,198
New +$728K 0.34% 81

Other funds holding CELG

Columbia Asset Management's CELG Position: Q4 2019 in Review

Columbia Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,532 shares — an estimated $450K sold.

Columbia Asset Management first reported a position in CELG in Q4 2013 and held it in 24 quarters. The position peaked at $870K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Columbia Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Columbia Asset Management sold 4,532 Celgene Corp shares in Q4 2019, an estimated $450K.
  • Columbia Asset Management first reported a position in Celgene Corp in Q4 2013 and held it in 24 quarters.
  • Columbia Asset Management's Celgene Corp position peaked at $870K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Columbia Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.